Metha 2017.

Methods	Randomized, double‐blinded, controlled trial. To analyse risk versus benefit of using intraoperative bolus of IV lignocaine (1.5 mg/kg) followed by constant rate (1.5 mg/kg/h) lignocaine for intraoperative and postoperative analgesic requirement in lower abdominal gynaecologic oncology surgeries. It is not stated where the study was conducted. Date not specified. Trial identifier: N/A
Participants	Sample size: 60 (2 groups, n = N/A) Inclusion criteria ASA I and II women scheduled for elective lower abdominal gynaecologic oncology surgeries Exclusion criteria N/A
Interventions	Experimental group (N/A patients) IV lignocaine 1.5 mg/kg bolus over 5 minutes preinduction followed by a continuous lignocaine infusion of 1.5 mg/kg/h until the end of surgery. Control group (N/A patients) Saline in a similar manner (control group).
Outcomes	Sedation, postoperative nausea and vomiting and need of anti‐emetic drugs, bowel mobility (passage of flatus and motion), incidence of pruritus, need of anti‐histaminic drugs, length of hospital stay, and postoperative analgesic requirement.
Notes	Small trial sample size (< 200 patients) Anaesthesia N/A Funding N/A Notes Only abstract available